Novarad’s augmented reality solution gains FDA clearance

Michael Walter | | Radiology Business | Practice Management

Novarad’s OpenSight Augmented Reality (AR) System is the first AR solution for Microsoft HoloLens to receive FDA clearance for pre-operative surgical planning, the company announced this week. OpenSight overlays 2D, 3D and 4D images over the patient’s body, helping them plan surgeries in advance.  

“This is transformative technology that will unite preoperative imaging with augmented reality to improve the precision, speed and safety of medical procedures,” Wendell Gibby, MD, Novarad CEO and co-creator of OpenSight, said in a prepared statement. “This internal visualization can now be achieved without the surgeon ever making an incision, improving outcomes in a world of more precise medicine.”

The technology allows providers to highlight certain parts of the body, position guidance systems ahead of the surgery and more. Medical students can also use the solution so train as they perform AR dissections on cadavers.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

‘Persistent’ low utilization of key interventional service raises radiologist concern
FDA clears Philips’ Radiology Operations Command Center for remote scanning
CMS approves new MRI standards related to remote scanning
Radiology group cancels hospital-based business to focus on outpatient center growth
Radiology provider Akumin breaks long radio silence after emerging from bankruptcy
Doc offices more than double use of nonphysicians for interpreting medical images

Around the web

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Cardiovascular Business
GE HealthCare moves PET/CT scanner production to United States

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.